Journal profile · Multiple
JBI Evidence Implementation
ISSN 2691-3321 · Wolters Kluwer Health · UNITED STATES
JBI Evidence Implementation: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.99; hybrid open access; 60 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JBI Evidence Implementation is published by Wolters Kluwer Health and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Health Policy Implementation Science, Health Sciences Research and Education and Primary Care and Health Outcomes, together about 32.3% of its articles. Its main subfields are General Health Professions. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- Health Policy Implementation ScienceHealth Professions14.5%
- Health Sciences Research and EducationHealth Professions12.2%
- Primary Care and Health OutcomesHealth Professions5.6%
- Meta-analysis and systematic reviewsDecision Sciences5.4%
- Clinical practice guidelines implementationMedicine5.2%
- Geriatric Care and Nursing HomesHealth Professions4.9%
- Palliative Care and End-of-Life IssuesMedicine4.9%
- Patient Safety and Medication ErrorsHealth Professions3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
| Minor | Medicine, General & Internal | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.99LetPub ·
- CiteScore 2026-06
- 2.2LetPub ·
- SJR 2026-06
- 0.45LetPub ·
- SNIP 2026-06
- 0.85LetPub ·
- h-index
- 66OpenAlex ·
- i10-index
- 358OpenAlex ·
- 2-year mean citedness
- 1.33OpenAlex ·
- Self-citation rate
- 30%LetPub ·
- Share of gold OA articles
- 21.38%LetPub ·
Volume
- Articles per year
- 58LetPub ·
Articles by year OpenAlex count · 1,828 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 95 | 70 | 12 |
| 2025 | 60 | 37 | 97 |
| 2024 | 84 | 28 | 210 |
| 2023 | 39 | 8 | 193 |
| 2022 | 58 | 12 | 431 |
| 2021 | 39 | 8 | 1,937 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 5 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- Country or region
- UNITED STATES
- ISSN
- 2691-3321
FAQ
Frequently asked questions about JBI Evidence Implementation
What CAS zone is JBI Evidence Implementation in?
In the 2025 upgraded edition of the CAS Journal Ranking, JBI Evidence Implementation is in Zone 4 of Medicine, and in Zone 4 of the minor category Health Care Sciences & Services / Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JBI Evidence Implementation?
The latest impact factor listed by LetPub is 1.99; CiteScore 2.2, h-index 66.
Which databases index JBI Evidence Implementation?
According to LetPub and DOAJ records, JBI Evidence Implementation is indexed in SCIE and Scopus.
Is JBI Evidence Implementation open access, and what is the APC?
JBI Evidence Implementation is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .